Is a review published in Chemistry – A European Journal, August 2019 DOI 10.1002/chem.201903232 Pubmed ID 31429510 Authors Oleksandr O Grygorenko, Dmitriy M. Volochnyuk, Sergey V. Ryabukhin, Duncan B. Judd
The CEO with be attending the SCI’s Fine Chemical Group one-day meeting to showcase cutting edge synthetic organic chemistry. The aim of the meeting is to highlight new synthetic approaches, disconnections and methods, and their application as developed by key researchers from both academia and industry. An exciting line up of leading academic and industrial scientists will present a series of lectures covering areas such as electrochemistry, C-H activation and new catalytic methods.
It describes how Bayer’s HTS collection was increased by 500 000 newly designed compounds within 5 years and how this collaborative project, which involved all internal medicinal chemists using a crowd-sourcing approach, along with selected external partners, reached this ambitious goal.
event which brings together stakeholders in pharmaceutical R&D outsourcing
to share experience, develop knowledge and skills and build new and existing
business partnerships. The scope of the event for 2019 will cover Discovery
Outsourcing and Development Stage CMC Outsourcing for both Small Molecules and
look forward to building on a highly successful event in 2018 where delegate
numbers increased by over 30% and average ratings reached 8 out of 10 (up from
7.68 in 2017). We look forward to developing the event further in 2019 to meet
all your Discovery and CMC outsourcing needs.
Go to https://www.bio2bevents.com/forthcoming-events/bos2019